In vitro Phenotype Induction of Circulating Monocytes: CD16 and CD163 Analysis

References

• Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116(16):e74–e80. doi:10.1182/blood-2010-02-258558
   PubMed Web of Science ®Google Scholar
• Ziegler-Heitbrock L. Blood monocytes and their subsets: established features and open questions. Front Immunol. 2015;6:423. doi:10.3389/fimmu.2015.00423
   PubMed Web of Science ®Google Scholar
• Burbano C, Vasquez G, Rojas M. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus. Arthritis Rheumatol. 2014;66(12):3371–3381. doi:10.1002/art.38860
   PubMed Web of Science ®Google Scholar
• Rana AK, Li Y, Dang Q, Yang F. Monocytes in rheumatoid arthritis: circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis. Int Immunopharmacol. 2018;65:348–359. doi:10.1016/j.intimp.2018.10.016
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Kanti Barman P, Kumar Thatoi P, Tripathy R, Kumar Das B, Ravindran B. Non-classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous. Sci Rep. 2015;5:13886. doi:10.1038/srep13886
   PubMed Web of Science ®Google Scholar
• Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum. 2012;64(3):671–677. doi:10.1002/art.33418
   PubMedGoogle Scholar
• Leers MPG, Stockem C, Ackermans D, et al. Intermediate and nonclassical monocytes show heterogeneity in patients with different types of acute coronary syndrome. Cytometry A. 2017;91(11):1059–1067. doi:10.1002/cyto.a.23263
   PubMedGoogle Scholar
• Wildgruber M, Czubba M, Aschenbrenner T, et al. Increased intermediate CD14(++)CD16(++) monocyte subset levels associate with restenosis after peripheral percutaneous transluminal angioplasty. Atherosclerosis. 2016;253:128–134. doi:10.1016/j.atherosclerosis.2016.09.002
   PubMed Web of Science ®Google Scholar
• SahBandar IN, Ndhlovu LC, Saiki K, et al. Relationship between circulating inflammatory monocytes and cardiovascular disease measures of carotid intimal thickness. J Atheroscler Thromb. 2020;27(5):441–448. doi:10.5551/jat.49791
   PubMed Web of Science ®Google Scholar
• Graziano F, Vicenzi E, Poli G. Plastic restriction of HIV-1 replication in human macrophages derived from M1/M2 polarized monocytes. J Leukoc Biol. 2016;100(5):1147–1153. doi:10.1189/jlb.4AB0316-158R
   PubMed Web of Science ®Google Scholar
• Ammirati E, Moroni F, Magnoni M, et al. Circulating CD14+ and CD14(high)CD16- classical monocytes are reduced in patients with signs of plaque neovascularization in the carotid artery. Atherosclerosis. 2016;255:171–178. doi:10.1016/j.atherosclerosis.2016.10.004
   PubMed Web of Science ®Google Scholar
• Thomas GD, Hamers AAJ, Nakao C, et al. Human blood monocyte subsets: a new gating strategy defined using cell surface markers identified by mass cytometry. Arterioscler Thromb Vasc Biol. 2017;37(8):1548–1558. doi:10.1161/ATVBAHA.117.309145
   PubMed Web of Science ®Google Scholar
• Fukui S, Iwamoto N, Takatani A, et al. M1 and M2 monocytes in rheumatoid arthritis: a contribution of imbalance of M1/M2 monocytes to osteoclastogenesis. Front Immunol. 2017;8:1958. doi:10.3389/fimmu.2017.01958
   PubMed Web of Science ®Google Scholar
• Williams H, Cassorla G, Pertsoulis N, et al. Human classical monocytes display unbalanced M1/M2 phenotype with increased atherosclerotic risk and presence of disease. Int Angiol. 2017;36(2):145–155. doi:10.23736/S0392-9590.16.03661-0
   PubMed Web of Science ®Google Scholar
• Hou J, Zhang M, Ding Y, et al. Circulating CD14(+)CD163(+)CD206(+) M2 monocytes are increased in patients with early stage of idiopathic membranous nephropathy. Mediators Inflamm. 2018;2018:5270657. doi:10.1155/2018/5270657
   PubMed Web of Science ®Google Scholar
• Boyette LB, Macedo C, Hadi K, et al. Phenotype, function, and differentiation potential of human monocyte subsets. PLoS One. 2017;12(4):e0176460. doi:10.1371/journal.pone.0176460
   PubMed Web of Science ®Google Scholar
• Karsulovic C, Lopez M, Tempio F, Guerrero J, Goecke A. mTORC inhibitor sirolimus deprograms monocytes in “cytokine storm” in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis-like syndrome. Clin Immunol. 2020;218:108539. doi:10.1016/j.clim.2020.108539
   PubMed Web of Science ®Google Scholar
• Gatti A, Radrizzani D, Vigano P, Mazzone A, Brando B. Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection. Cytometry A. 2020;97(9):887–890. doi:10.1002/cyto.a.24188
   PubMed Web of Science ®Google Scholar
• Fogg KC, Miller AE, Li Y, et al. Ovarian cancer cells direct monocyte differentiation through a non-canonical pathway. BMC Cancer. 2020;20(1):1008. doi:10.1186/s12885-020-07513-w
   PubMed Web of Science ®Google Scholar
• Motz K, Lina I, Murphy MK, et al. M2 macrophages promote collagen expression and synthesis in laryngotracheal stenosis fibroblasts. Laryngoscope. 2020. doi:10.1002/lary.28980
   Web of Science ®Google Scholar
• Krijgsman D, De Vries NL, Andersen MN, et al. CD163 as a biomarker in colorectal cancer: the expression on circulating monocytes and tumor-associated macrophages, and the soluble form in the blood. Int J Mol Sci. 2020;21(16).
   Web of Science ®Google Scholar
• Foster B, Prussin C, Liu F, Whitmire JK, Whitton JL. Detection of intracellular cytokines by flow cytometry. Curr Protoc Immunol. 2007;Chapter 6:Unit 6 24. doi:10.1002/0471142735.im0624s78
   Google Scholar